Hot of the press: BIOTECH Insight Newsletter
Deutsche Börse report key growth figures of the German biotech sector in 2021 in BIOTECH Insight, its new online information service published in collaboration with BIOCOM AG.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1125 entries already.
Entries by Thomas Gabrielczyk
Engimmune Therapeutics raises CHF15.5m in seed financing
/in News/by Thomas GabrielczykCancer specialist Engimmune Therapeutics has raised CHF15.5m in a seed financing to expand its pipeline of T-cell receptor therapeutics.
Switzerland shows sustained growth of biotech sector
/in News/by Thomas GabrielczykThe Swiss Biotech sector has again attracted record-breaking investments in 2021, according to the Swiss Biotech Report that was presented at the Swiss Biotech Day 2022 in Basel.
Replacing beef with cellular protein halves deforestation
/in News/by Thomas GabrielczykReplacing 20% of global beef consumption with fermentation-derived microbial protein by 2050 could halve annual deforestation and associated carbon dioxide emissions.
Commission to establish EU health data space
/in News/by Thomas GabrielczykDigital medicine holds great opportunities. The EU Commission is therefore presenting a draft law this week that defines rules for a European Health Data Space.
Four new autoantigens trigger multiple sclerosis
/in News/by Thomas GabrielczykSwiss and Swedish researchers have uncovered four previously unkown autoantigens that trigger multiple sclerosis in mice.
TWB partners with Processium and Syngulon
/in News/by Thomas GabrielczykIndustrial biotech project managment specialist Toulouse White Biotech (TWB) has joined forces with process developer Processium and industrial synbio start-up Syngulon.
Meat consumption must fall by at least 75 percent
/in News/by Thomas GabrielczykIf our planet is to continue feeding us in the future, rich countries must significantly reduce their meat consumption by at least 75% suggests a new study by German researchers.
Vigeneron updates gene therapy collab with Daiichi Sankyo
/in News/by Thomas GabrielczykViGeneron and Daiichi Sankyo have agreed a follow-on collaboration to evaluate vgAAVs as vectors for Daiichi Sankyo novel treatment of prevalent eye diseases.
Single-use market to reach $20.8bn by 2026
/in News/by Thomas GabrielczykAnalysts from Markets & Markets today released the report "Single use Bioprocessing Market by Product.